Total Payments
$612.51
2024 Payments
$129.16
Companies
11
Transactions
36
Medicare Patients
4,397
Medicare Billing
$801,754
Payment Breakdown by Category
Food & Beverage$612.51 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $612.51 | 36 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $194.03 | 11 | $0 (2024) |
| ABBVIE INC. | $124.17 | 5 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $92.50 | 7 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $78.24 | 5 | $0 (2023) |
| Allergan Inc. | $25.05 | 2 | $0 (2017) |
| GlaxoSmithKline, LLC. | $24.16 | 1 | $0 (2021) |
| Qiagen, LLC | $18.88 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $15.33 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $14.20 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $13.13 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $129.16 | 5 | ABBVIE INC. ($80.82) |
| 2023 | $36.98 | 2 | Janssen Pharmaceuticals, Inc ($36.98) |
| 2022 | $57.55 | 3 | ABBVIE INC. ($43.35) |
| 2021 | $76.04 | 4 | GlaxoSmithKline, LLC. ($24.16) |
| 2019 | $64.58 | 4 | PFIZER INC. ($64.58) |
| 2018 | $102.86 | 7 | PFIZER INC. ($53.70) |
| 2017 | $145.34 | 11 | Merck Sharp & Dohme Corporation ($56.16) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $28.34 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/16/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/22/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $30.04 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: VACCINES | ||||||
| 01/16/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: VACCINES | ||||||
| 11/20/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/02/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/10/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/11/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/13/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.20 | General |
| Category: Cardiovascular | ||||||
| 12/15/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/13/2021 | Qiagen, LLC | QUANTIFERON-TB GOLD PLUS (Device) | Food and Beverage | Cash or cash equivalent | $18.88 | General |
| Category: DEVICES | ||||||
| 09/27/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/12/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/24/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/25/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/13/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/12/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/04/2018 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/01/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/02/2018 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/23/2018 | Cumberland Pharmaceuticals, Inc. | Caldolor (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Anesthesiology (Pain Management) | ||||||
| 07/31/2018 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/03/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 1,295 | 1,377 | $2.0M | $232,813 |
| 2022 | 4 | 1,235 | 1,295 | $1.8M | $244,352 |
| 2021 | 4 | 969 | 1,007 | $1.4M | $171,253 |
| 2020 | 4 | 898 | 941 | $1.3M | $153,336 |
Total Patients
4,397
Total Services
4,620
Medicare Billing
$801,754
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 747 | 803 | $1.2M | $136,231 | 11.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 340 | 359 | $676,356 | $75,520 | 11.2% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 140 | 147 | $146,412 | $15,800 | 10.8% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 56 | 56 | $29,400 | $3,643 | 12.4% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2023 | 12 | 12 | $14,652 | $1,619 | 11.1% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 785 | 839 | $1.2M | $167,601 | 13.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 199 | 200 | $376,800 | $50,157 | 13.3% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 180 | 183 | $182,268 | $21,662 | 11.9% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 71 | 73 | $38,325 | $4,931 | 12.9% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 587 | 620 | $909,540 | $110,964 | 12.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 177 | 179 | $337,236 | $37,642 | 11.2% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 159 | 162 | $161,352 | $19,369 | 12.0% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 46 | 46 | $24,150 | $3,278 | 13.6% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 533 | 572 | $839,124 | $95,252 | 11.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 190 | 191 | $359,844 | $41,589 | 11.6% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 110 | 113 | $112,548 | $12,567 | 11.2% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 65 | 65 | $34,125 | $3,928 | 11.5% |
About Dr. Sayed Khwaja, D.O
Dr. Sayed Khwaja, D.O is a Emergency Medicine healthcare provider based in Stony Brook, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780612648.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sayed Khwaja, D.O has received a total of $612.51 in payments from pharmaceutical and medical device companies, with $129.16 received in 2024. These payments were reported across 36 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($612.51).
As a Medicare-enrolled provider, Khwaja has provided services to 4,397 Medicare beneficiaries, totaling 4,620 services with total Medicare billing of $801,754. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location Stony Brook, NY
- Active Since 06/29/2006
- Last Updated 07/08/2007
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1780612648
Products in Payments
- DALVANCE (Drug) $138.84
- ZERBAXA (Drug) $92.50
- CHANTIX (Drug) $80.10
- ELIQUIS (Drug) $79.79
- XARELTO (Drug) $78.24
- PREVNAR 20 (Biological) $48.34
- TRELEGY ELLIPTA (Drug) $24.16
- QUANTIFERON-TB GOLD PLUS (Device) $18.88
- BRILINTA (Drug) $15.33
- ENTRESTO (Drug) $13.13
- Caldolor (Drug) $12.82
- AVYCAZ (Drug) $10.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Stony Brook
Dr. Adam Singer, M.d, M.D
Emergency Medicine — Payments: $675,767
Emergency Medicine $675,767
Paul Taglienti, Md, MD
Emergency Medicine — Payments: $1,924
Emergency Medicine $1,924
Dr. Jose Torres, Md, MD
Emergency Medicine — Payments: $1,565
Emergency Medicine $1,565
Dr. Lawrence Schiff, Md, MD
Emergency Medicine — Payments: $1,071
Emergency Medicine $1,071
Dr. Joseph Corcoran, Md, MD
Emergency Medicine — Payments: $813.09
Emergency Medicine $813.09
Dr. Jerome Wilkerson, M.d, M.D
Emergency Medicine — Payments: $499.23
Emergency Medicine $499.23